Lv2
122 积分 2025-03-01 加入
Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog
7个月前
已完结
Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
8个月前
已完结
Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
8个月前
已完结
Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog
8个月前
已完结
Current Trend in Antiviral Therapy for Chronic Hepatitis B
8个月前
已完结
Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
8个月前
已完结
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
8个月前
已完结
The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: a systematic review and meta-analysis
8个月前
已完结
Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis
8个月前
已完结
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
8个月前
已完结
皖公网安备34019202002308
